{"id":76998,"date":"2026-05-06T06:53:11","date_gmt":"2026-05-06T06:53:11","guid":{"rendered":"https:\/\/www.europesays.com\/cz\/76998\/"},"modified":"2026-05-06T06:53:11","modified_gmt":"2026-05-06T06:53:11","slug":"biotechnologie-z-ceska-lakaji-stovky-milionu-dolaru","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/cz\/76998\/","title":{"rendered":"Biotechnologie z \u010ceska l\u00e1kaj\u00ed stovky milion\u016f dolar\u016f"},"content":{"rendered":"

Glob\u00e1ln\u00ed investo\u0159i nach\u00e1zej\u00ed nov\u00fd cenn\u00fd zdroj pro parkov\u00e1n\u00ed rizikov\u00e9ho kapit\u00e1lu. Le\u017e\u00ed v \u010cesku a okoln\u00edch zem\u00edch. Jeho t\u011b\u017ei\u0161t\u011bm jsou biotechnologie, tedy obor s ambic\u00ed nach\u00e1zet pomoc\u00ed bun\u011bk, enzym\u016f a dal\u0161\u00edch \u017eiv\u00fdch n\u00e1stroj\u016f cestu k lep\u0161\u00edmu lidsk\u00e9mu zdrav\u00ed \u010di \u017eivotn\u00edmu prost\u0159ed\u00ed. Roste po\u010det startup\u016f i investic do nich. Jen vloni investo\u0159i vlo\u017eili do startup\u016f z oboru v regionu 140 milion\u016f dolar\u016f.\u00a0<\/p>\n

\u010c\u00edsla z datab\u00e1ze Dealroom zazn\u011bla na v\u011bdeck\u00e9 konferenci BioEquity Europe 2026. Je to poprv\u00e9 v jej\u00ed 26let\u00e9 historii, co se konala na v\u00fdchod od n\u011bmeck\u00fdch hranic, a pr\u00e1v\u011b investice s t\u00edm maj\u00ed co do \u010din\u011bn\u00ed. \u201eRegion je dnes pro investory zaj\u00edmav\u00fd nejen kv\u016fli talentu a kvalitn\u00ed v\u011bd\u011b, ale i d\u00edky rostouc\u00edmu po\u010dtu firem, kter\u00e9 jsou schopn\u00e9 pracovat v glob\u00e1ln\u00edm m\u011b\u0159\u00edtku,\u201c \u0159ekl Radek \u0160p\u00ed\u0161ek, CEO spole\u010dnosti Sotio Biotech.\u00a0<\/p>\n

\"\u010cesko<\/a>\u010cesko otev\u0159elo zdarma sv\u011btu datab\u00e1zi, kter\u00e1 m\u016f\u017ee urychlit hled\u00e1n\u00ed nov\u00fdch l\u00e9k\u016f<\/a><\/p>\n

Pro p\u0159\u00edklady nen\u00ed v \u010cesku pot\u0159eba chodit daleko. Spole\u010dnost CasInvent Pharma vyv\u00edj\u00ed patentovan\u00e9 l\u00e1tky, kter\u00e9 hraj\u00ed d\u016fle\u017eitou roli p\u0159i vzniku z\u00e1va\u017en\u00fdch rakovinov\u00fdch onemocn\u011bn\u00ed. Jde o spin-off Masarykovy univerzity. Investo\u0159i v \u010dele s fondem Khan Technology Transfer Fund do firmy p\u0159ed \u010dasem vstoupili \u010d\u00e1stkou p\u0159esahuj\u00edc\u00ed milion eur.\u00a0<\/p>\n

\u0158e\u010d je o boomu, kter\u00fd obor v regionu za\u017e\u00edv\u00e1. St\u0159edn\u00ed a v\u00fdchodn\u00ed Evropa a Pobalt\u00ed zaznamenaly obrat v sektoru biotechnologi\u00ed a zdravotnick\u00fdch technologi\u00ed v objemu 56 miliard eur a celkov\u00fd r\u016fst hrub\u00e9 p\u0159idan\u00e9 hodnoty \u010dinil mezi lety 2008\u20132022 pln\u00fdch 130 procent. V oboru v regionu pracuje t\u00e9m\u011b\u0159 900 tis\u00edc zam\u011bstnanc\u016f s vysokou p\u0159idanou hodnotou.\u00a0<\/p>\n

Co se\u00a0\u010ceska<\/a>\u00a0t\u00fdk\u00e1, podle anal\u00fdzy, kterou provedla biotechnologick\u00e1 asociace Prague.bio, biotechnologick\u00fd sektor zahrnuje 430 subjekt\u016f,<\/a>\u00a0a\u0165 ji\u017e firem \u010di v\u00fdzkumn\u00fdch instituc\u00ed, kter\u00e9 ro\u010dn\u011b generuj\u00ed p\u0159\u00edjmy 97,5 miliardy korun. \u201eZahrani\u010dn\u00ed investo\u0159i dob\u0159e vn\u00edmaj\u00ed pozitivn\u00ed v\u00fdvoj sektoru biotechnologi\u00ed v regionu a cht\u011bj\u00ed b\u00fdt u toho. V\u00fdhodou Prahy a \u010ceska v jejich o\u010d\u00edch je, \u017ee tvo\u0159\u00ed vstupn\u00ed br\u00e1nu do cel\u00e9 st\u0159edn\u00ed a v\u00fdchodn\u00ed Evropy,\u201c komentoval Ji\u0159\u00ed Fusek, v\u00fdkonn\u00fd \u0159editel Prague.bio, kter\u00e1 propojuje tuzemsk\u00e9 v\u011bdeck\u00e9 prost\u0159ed\u00ed, ve\u0159ejn\u00e9 instituce a byznys.\u00a0<\/p>\n

\"Zlep\u0161il<\/a>Zlep\u0161il senior\u016fm ukazatele zdrav\u00ed a\u017e o \u010dty\u0159i roky. Dok\u00e1\u017eeme v\u00edc, \u0159\u00edk\u00e1 investor p\u0159ed sout\u011b\u017e\u00ed v dlouhov\u011bkosti<\/a><\/p>\n

A podle \u010d\u00edsel investo\u0159i na boom biotechnologi\u00ed sly\u0161\u00ed. Po\u010det investi\u010dn\u00edch kol v posledn\u00edch letech sice klesl, objem pen\u011bz v sektoru ale z\u016fst\u00e1v\u00e1 siln\u00fd. V roce 2025 se po p\u0159edchoz\u00edm poklesu znovu vr\u00e1til k r\u016fstu a pohybuje se okolo 140 milion\u016f dolar\u016f.\u00a0<\/p>\n

\u201eVzhledem k p\u0159\u00edzniv\u00e9mu pom\u011bru kvality a ceny je region\u00e1ln\u00ed biotechnologick\u00fd v\u00fdzkum zaj\u00edmavou alternativou. M\u00e1me velkou radost, \u017ee se na jeho rozvoji formou zakl\u00e1d\u00e1n\u00ed startup\u016f pod\u00edl\u00ed rostouc\u00ed mno\u017estv\u00ed mlad\u00fdch v\u011bdc\u016f nejen ze zem\u00ed regionu, ale i z cel\u00e9ho sv\u011bta,\u201c \u0159\u00edk\u00e1 Milan Pr\u00e1\u0161il, \u0159editel IOCB Tech, kter\u00e1 propojuje v\u011bdu s prax\u00ed, hlavn\u011b v oblasti chemie, biotechnologi\u00ed a v\u00fdvoje l\u00e9k\u016f.\u00a0<\/p>\n

Cesta pro samotn\u00e9 v\u011bdce a jejich startupy ov\u0161em nen\u00ed zdaleka jednoduch\u00e1, jak popsal biochemik Jan Konvalinka, \u0159editel \u00dastavu organick\u00e9 chemie a biochemie Akademie v\u011bd. \u201eMus\u00ed vznikat mal\u00e9 firmy, startupy zalo\u017een\u00e9 na na\u0161ich vlastn\u00edch patentech, kter\u00e9 mus\u00ed z\u00edskat investory z domova nebo ze zahrani\u010d\u00ed. Je pot\u0159eba jejich v\u00fdzkum dotla\u010dit p\u0159es \u00fadol\u00ed smrti a\u017e do preklinick\u00fdch nebo po\u010d\u00e1te\u010dn\u00edch klinick\u00fdch zkou\u0161ek, aby p\u0159i\u0161el z\u00e1jem velk\u00fdch farmaceutick\u00fdch firem,\u201c vyjmenoval. Pro to je ale pot\u0159eba tak\u00e9 pomoc st\u00e1tu, konkr\u00e9tn\u011b podpora z\u00e1kladn\u00edho v\u00fdzkumu a legislativa, kter\u00e1 d\u00e1v\u00e1 r\u00e1mec p\u0159echodu projekt\u016f z akademick\u00e9ho do komer\u010dn\u00edho prost\u0159ed\u00ed.\u00a0<\/p>\n

\"V\u011bdci<\/a>V\u011bdci z Brna rozlouskli genetickou poruchu \u010dastou u ami\u0161\u016f. V\u00fdzkum m\u016f\u017ee v\u00e9st a\u017e k l\u00e9\u010db\u011b n\u00e1dor\u016f<\/a><\/p>\n

Podle m\u00edstop\u0159edsedy vl\u00e1dy Karla Havl\u00ed\u010dka z hnut\u00ed ANO takov\u00e9 kroky zapadaj\u00ed do hospod\u00e1\u0159sk\u00e9 strategie vl\u00e1dy. Jako symbol \u00fasp\u011bchu p\u0159ipomn\u011bl z\u00e1vody z\u00e1padn\u00edho sv\u011bta s \u010c\u00ednou o v\u011bdeckou nadvl\u00e1du. \u201e\u010c\u00edna je dnes velmi siln\u00e1 nikoli t\u00edm, \u017ee m\u00e1 levnou pracovn\u00ed s\u00edlu nebo \u017ee kop\u00edruje, co by se zkop\u00edrovat dalo, to je minulost. \u010c\u00edna je dobr\u00e1 proto, \u017ee zav\u010dasu pochopila, \u017ee pr\u00e1v\u011b ve v\u00fdzkumu a inovac\u00edch je z\u00e1klad rozvoje, a lije do toho neuv\u011b\u0159iteln\u00e9 prost\u0159edky. Por\u00e1\u017e\u00ed n\u00e1s na\u0161imi vlastn\u00edmi zbran\u011bmi,\u201c \u0159ekl.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Glob\u00e1ln\u00ed investo\u0159i nach\u00e1zej\u00ed nov\u00fd cenn\u00fd zdroj pro parkov\u00e1n\u00ed rizikov\u00e9ho kapit\u00e1lu. Le\u017e\u00ed v \u010cesku a okoln\u00edch zem\u00edch. Jeho t\u011b\u017ei\u0161t\u011bm…\n","protected":false},"author":2,"featured_media":76999,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[7288,24812,67,68,42,202,2046,1099,4414,24811,77,4095],"class_list":{"0":"post-76998","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-byznys","8":"tag-akademie-ved","9":"tag-biotechnologie","10":"tag-business","11":"tag-byznys","12":"tag-cesko","13":"tag-cina","14":"tag-dolar","15":"tag-investor","16":"tag-stredni-a-vychodni-evropa","17":"tag-uochb","18":"tag-veda","19":"tag-vyzkum"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@cz\/116526317818705484","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/76998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/comments?post=76998"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/posts\/76998\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media\/76999"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/media?parent=76998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/categories?post=76998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/cz\/wp-json\/wp\/v2\/tags?post=76998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}